Thrombolytic therapy for acute myocardial infarction

Medicine and Dentistry

• Thrombolytic Drug 100%
• Acute Heart Infarction 100%
• Fibrinolytic Therapy 100%
• Infarction 57%
• Cerebral Hemorrhage 28%
• Cardiogenic Shock 28%
• Blood Pressure 14%
• Diabetes Mellitus 14%
• Myocardial Infarction 14%
• Cerebrovascular Disease 14%
• Risk Reduction 14%
• Bleeding 14%
• Patient History of Coronary Artery Bypass Graft 14%
• Blood Clot Lysis 14%
• Transluminal Coronary Angioplasty 14%
• Elderly Patient 14%
• Coronary Artery Bypass Surgery 14%
• Reteplase 14%
• Cardiopulmonary Resuscitation 14%
• Streptokinase 14%
• Contraindication 14%
• Tenecteplase 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Heart Infarction 100%
• Fibrinolytic Agent 100%
• Infarction 50%
• Brain Hemorrhage 25%
• Cardiogenic Shock 25%
• Heart Infarction 12%
• Bleeding 12%
• Patient History of Coronary Artery Bypass Graft 12%
• Diabetes Mellitus 12%
• Cerebrovascular Disease 12%
• Streptokinase 12%
• Reteplase 12%
• Anistreplase 12%
• Tenecteplase 12%